Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment

Fig 1

Incidence of chronic kidney disease among patients who developed mild renal impairment during tenofovir-containing antiretroviral treatment.

eGFR was calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula.[8] Mild renal impairment was defined as two consecutive eGFR between 89 and 60 ml/min during TDF treatment. Chronic Kidney Disease was defined as two eGFR <60 ml/min measured 3–6 months apart. Abbreviations: Pt-yrs, patient-years; TDF, tenofovir disoproxil fumarate.

Fig 1